CD20-позитивные B-лимфоциты в реактивном микроокружении опухоли как независимый иммуногистохимический фактор прогноза при нодулярном склерозе классической лимфомы Ходжкина
Article in Clinical oncohematology (April 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Chapter 8 Clinical relevance and therapeutic implications of CD20 expression in Hodgkin's lymphoma
Book chapter (January 2024)
CD20 expression is closely associated with Epstein–Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma
Article in Frontiers in Oncology (September 2022)